new drug application
Pan-Asian Trials Could Replace Domestic Studies
Improved adherence to ICH guidelines means that data from Asia-wide trials could be extrapolated to specific countries.
Takeda’s ADCETRIS® Approved For Lymphoma Treatment In Japan
Takeda's ADCETRIS® has been approved for the treatment of patients with certain types of lymphoma in Japan.




